Cell And Gene Therapy

Pic:getty/richarddrury

mRNA and beyond: Opportunities for US biologics

By Staff reporter

The success of mRNA vaccine technology could be one of the new opportunities for US pharmaceutical manufacturing looking forward, with pandemic investments helping turbocharge the sector.

(Image: Getty/Tuomas Lehitnen)

SGS’ Glasgow biosafety facility doubles in size

By Maggie Lynch

SGS’ completed the ₤8.7m expansion of its large molecule testing facility in Glasgow and made room to increase its existing biosafety service and PCR platform capabilities.

(Image: Getty/scanrail)

Scaling down: Clinical research shifts its focus

By Maggie Lynch

Smaller company’s last year led in new drug approvals, nearly half of which were for the treatment of rare diseases, as the industry shifts away from the need to scale infrastructure, says Tufts director.

(Image: PPD)

PPD adds biologics testing to GMP lineup in Ireland

By Melissa Fassbender

PPD is adding nearly 6,000 square feet of new lab space – and about 20 employees – dedicated to gene and cell therapy analytical testing at its site in Athlone, Ireland.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All